You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herpesviridae Infections

Showing 1 - 25 of 7,115
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn Trial in Chongqing

Recruiting
  • Vaccination Reaction
  • +4 more
    • Chongqing, Chongqing, China
      Children's Hospital of Chongqing Medical University
    Sep 7, 2023

    Intravenous Acyclovir in Oncologic Paediatric Patients

    Active, not recruiting
    • Herpesviridae Infections
    • +4 more
    • Pharmacokinetic analysis
    • Trieste, TS, Italy
      IRCCS Burlo Garofolo, Bone Marrow Transplant Unit, Institute for
    Jan 19, 2022

    Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
    • (no location specified)
    Jun 12, 2023

    Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

    Not yet recruiting
    • Chronic Hepatitis B
    • (no location specified)
    Feb 28, 2023

    Hepatitis B Virus Infection Trial in Changsha (Standard antiviral therapy)

    Recruiting
    • Hepatitis B Virus Infection
    • Standard antiviral therapy
    • Changsha, Hunan, China
      Department of Infectious Disease, Xiangya Hospital, Central Sout
    May 22, 2022

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Herpes Simplex, Genital Trial in Belgium (2LHERP®, Placebo)

    Recruiting
    • Herpes Simplex, Genital
    • Lodelinsart, Charleroi, Belgium
    • +14 more
    Dec 22, 2022

    Treating Genital Herpes Infection to Reduce Racial Disparities

    Not yet recruiting
    • Genital Herpes Simplex
    • +2 more
      • Oakland, California
        Division of Research, Kaiser Permanente Northern California
      Jun 22, 2022

      Chronic Hepatitis B Virus Infection in Zambia

      Active, not recruiting
      • HBV
      • +5 more
      • Standard of care
      • Lusaka, Zambia
        Tropical Gastroenterology and Nutrition Group
      Jun 1, 2022

      Chronic Hepatitis B Virus Infection Trial in Guangzhou (Entecavir, Entecavir combined with Tenofovir Amibufenamide)

      Recruiting
      • Chronic Hepatitis B Virus Infection
      • Entecavir
      • Entecavir combined with Tenofovir Amibufenamide
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-sen University
      May 15, 2022

      Hepatitis B Virus Infection Trial in Hannover (No intervention)

      Recruiting
      • Hepatitis B Virus Infection
      • No intervention
      • Hannover, Germany
        Hannover Medical School
      Sep 20, 2021

      Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

      Recruiting
      • Chronic Hepatitis b
      • test of HBV DNA
      • Xi'an, Shaanxi, China
        First Affiliated Hospital of Xi'an JiaotongUniversity
      Mar 28, 2022

      Chronic Hepatitis B Virus Infection Trial in Kaohsiung, Taichung, Taipei (Ropeginterferon alfa-2b, Entecavir)

      Recruiting
      • Chronic Hepatitis B Virus Infection
      • Kaohsiung, Taiwan
      • +4 more
      Aug 12, 2022

      Chronic Hepatitis b Trial in Adelaide (Therapeutic hepatitis B vaccine, Commercial Hepatitis B vaccine)

      Not yet recruiting
      • Chronic Hepatitis b
      • Therapeutic hepatitis B vaccine
      • Commercial Hepatitis B vaccine
      • Adelaide, South Australia, Australia
        Flinders University
      Mar 7, 2022

      Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

      Terminated
      • Hepatitis B, Chronic
      • Hepatitis D
      • Chisinau, Republic Of Moldova, Moldova, Republic of
      • +1 more
      Nov 15, 2022

      Options for Genital Herpes Infection to Reduce Adverse Pregnancy

      Completed
      Has Results
      • HSV-2 Infection
      • +2 more
        • Oakland, California
          Division of Research
        Aug 23, 2021

        Advanced Hepatocellular Carcinoma Trial in Taipei City (Durvalumab)

        Recruiting
        • Advanced Hepatocellular Carcinoma
        • Taipei City, Taiwan
          National Taiwan University Hospital
        Nov 12, 2021

        Chronic Hepatitis b Trial in Chisinau, Kyiv (ATI-2173 25mg, Vebicorvir 300mg, Viread 300Mg Tablet)

        Terminated
        • Chronic Hepatitis b
        • ATI-2173 25mg
        • +2 more
        • Chisinau, Republic Of Moldova, Moldova, Republic of
        • +1 more
        May 25, 2022

        Chronic Hepatitis B Virus Infection Trial in Auckland (EDP-721, Placebo (Part 1), EDP-721 (Part 2))

        Terminated
        • Chronic Hepatitis B Virus Infection
        • Auckland, New Zealand
          New Zealand Clinical Research Ltd
        Feb 2, 2022

        Hepatitis B Trial in Baltimore (Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni], Sofosbuvir 400 MG [Sovaldi],

        Completed
        Has Results
        • Hepatitis B
        • Ledipasvir 90 MG / Sofosbuvir 400 MG Oral Tablet [Harvoni]
        • +2 more
        • Baltimore, Maryland
          Institute of Human Virology (IHV), University of Maryland Baltim
        Aug 24, 2021

        Hepatitis B Trial in Worldwide (JNJ-73763989, JNJ-56136379, Entecavir (ETV))

        Active, not recruiting
        • Hepatitis B
        • Baltimore, Maryland
        • +9 more
        Jan 17, 2023

        Hepatitis B, Chronic Trial in Worldwide (Cetrelimab, Placebo)

        Recruiting
        • Hepatitis B, Chronic
        • Edegem, Belgium
        • +13 more
        Jul 5, 2022

        Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, JNJ-64300535, ETV monohydrate)

        Active, not recruiting
        • Hepatitis B, Chronic
        • Edegem, Belgium
        • +12 more
        Jan 17, 2023

        Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

        Terminated
        • Hepatitis B, Chronic
        • Hillsborough, New Jersey
        • +11 more
        Dec 28, 2022